These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2450849)

  • 1. Antitumor actions of interferons. Direct, indirect, and synergy with other treatment modalities.
    Tyring SK
    Int J Dermatol; 1987 Nov; 26(9):549-56. PubMed ID: 2450849
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferons: biological and clinical effects.
    Nelson BE; Borden EC
    Semin Surg Oncol; 1989; 5(6):391-401. PubMed ID: 2480628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferons and cancer: how the promise is being kept.
    Borden EC
    Interferon; 1983; 5():43-83. PubMed ID: 6202643
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of interferon action.
    Schwarz LA; Fleischmann WR
    Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical value of interferons as antitumor agents.
    Billiau A
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):949-67. PubMed ID: 6173223
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-tumor effects of interferon (author's transl)].
    Sun Y
    Zhonghua Yi Xue Za Zhi; 1981 Sep; 61(9):556-8. PubMed ID: 6176299
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon.
    Horoszewicz JS
    Prostate; 1984; 5(2):213-9. PubMed ID: 6200869
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor effects of interferons.
    Friedman RM
    J Exp Pathol; 1987; 3(2):203-27. PubMed ID: 2447252
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferons: pleiotropic cellular modulators.
    Borden EC
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S18-24. PubMed ID: 1370263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon and malignant disease--how does it work and why doesn't it always?
    Grandér D; Einhorn S
    Acta Oncol; 1998; 37(4):331-8. PubMed ID: 9743454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of BRMs with chemotherapy.
    Tursz T
    Am J Med; 1995 Dec; 99(6A):56S-58S. PubMed ID: 8585538
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumour actions of interferons: implications for cancer therapy.
    Parker BS; Rautela J; Hertzog PJ
    Nat Rev Cancer; 2016 Mar; 16(3):131-44. PubMed ID: 26911188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alpha and gamma interferons and cytostatics on ovarian cancer in the subrenal capsule assay.
    Grönroos M; Mäenpää J; Söderström KO; Kangas L; Leppänen M; Cantell K
    Med Biol; 1983; 61(5):275-9. PubMed ID: 6200736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumoricidal biological response modifiers (BRM)].
    Niitsu Y; Kohgo Y; Watanabe N
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1407-13. PubMed ID: 1697152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferons as biochemical modulators.
    Borden EC; Wadler S
    J Clin Oncol; 1996 Oct; 14(10):2627-30. PubMed ID: 8874320
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia.
    Fuggetta MP; D'Onofrio C; Bonmassar E
    Ann Ist Super Sanita; 1990; 26(3-4):385-95. PubMed ID: 1708953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of chronic myelogenous leukemia: chemotherapy and interferons.
    Talpaz M; Kantarjian HM; Kurzrock R; Gutterman J
    Semin Hematol; 1988 Jan; 25(1):62-73. PubMed ID: 2450402
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferons in renal-cell carcinoma: status and prospects.
    De Mulder PH; Debruyne FM; Beniers AJ
    Prog Clin Biol Res; 1990; 348():49-59. PubMed ID: 1696737
    [No Abstract]   [Full Text] [Related]  

  • 19. Overview of biotherapy and nursing considerations.
    Coleman C
    J Intraven Nurs; 1998; 21(6):367-73. PubMed ID: 10392103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alfa interferon: combinations with other antineoplastic modalities.
    Bonnem EM
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):48-60. PubMed ID: 3296212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.